JP2020510656A5 - - Google Patents

Download PDF

Info

Publication number
JP2020510656A5
JP2020510656A5 JP2019546401A JP2019546401A JP2020510656A5 JP 2020510656 A5 JP2020510656 A5 JP 2020510656A5 JP 2019546401 A JP2019546401 A JP 2019546401A JP 2019546401 A JP2019546401 A JP 2019546401A JP 2020510656 A5 JP2020510656 A5 JP 2020510656A5
Authority
JP
Japan
Prior art keywords
ala
val
phe
lys
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019546401A
Other languages
English (en)
Japanese (ja)
Other versions
JP7106560B2 (ja
JP2020510656A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/019874 external-priority patent/WO2018160539A1/en
Publication of JP2020510656A publication Critical patent/JP2020510656A/ja
Publication of JP2020510656A5 publication Critical patent/JP2020510656A5/ja
Priority to JP2022112146A priority Critical patent/JP7645843B2/ja
Application granted granted Critical
Publication of JP7106560B2 publication Critical patent/JP7106560B2/ja
Priority to JP2025033022A priority patent/JP2025087787A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019546401A 2017-02-28 2018-02-27 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート Active JP7106560B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022112146A JP7645843B2 (ja) 2017-02-28 2022-07-13 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP2025033022A JP2025087787A (ja) 2017-02-28 2025-03-03 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762465118P 2017-02-28 2017-02-28
US62/465,118 2017-02-28
US201762480209P 2017-03-31 2017-03-31
US62/480,209 2017-03-31
PCT/US2018/019874 WO2018160539A1 (en) 2017-02-28 2018-02-27 Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022112146A Division JP7645843B2 (ja) 2017-02-28 2022-07-13 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート

Publications (3)

Publication Number Publication Date
JP2020510656A JP2020510656A (ja) 2020-04-09
JP2020510656A5 true JP2020510656A5 (cg-RX-API-DMAC7.html) 2021-04-08
JP7106560B2 JP7106560B2 (ja) 2022-07-26

Family

ID=61617182

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019546401A Active JP7106560B2 (ja) 2017-02-28 2018-02-27 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP2022112146A Active JP7645843B2 (ja) 2017-02-28 2022-07-13 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP2025033022A Pending JP2025087787A (ja) 2017-02-28 2025-03-03 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022112146A Active JP7645843B2 (ja) 2017-02-28 2022-07-13 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP2025033022A Pending JP2025087787A (ja) 2017-02-28 2025-03-03 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート

Country Status (13)

Country Link
US (4) US10792372B2 (cg-RX-API-DMAC7.html)
EP (1) EP3589328A1 (cg-RX-API-DMAC7.html)
JP (3) JP7106560B2 (cg-RX-API-DMAC7.html)
KR (3) KR102891599B1 (cg-RX-API-DMAC7.html)
CN (3) CN116785450A (cg-RX-API-DMAC7.html)
AU (2) AU2018229277B2 (cg-RX-API-DMAC7.html)
CA (1) CA3054608A1 (cg-RX-API-DMAC7.html)
IL (4) IL298414B2 (cg-RX-API-DMAC7.html)
MA (1) MA47815A (cg-RX-API-DMAC7.html)
RU (1) RU2765098C2 (cg-RX-API-DMAC7.html)
SG (2) SG11201907693VA (cg-RX-API-DMAC7.html)
TW (3) TWI862991B (cg-RX-API-DMAC7.html)
WO (1) WO2018160539A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2661466T3 (es) 2011-04-01 2018-04-02 Immunogen, Inc. Métodos para aumentar la eficacia de la terapia contra el cáncer con FOLR1
CA3042428A1 (en) 2016-11-08 2018-05-17 Regeneron Pharmaceuticals, Inc. Steroids and protein-conjugates thereof
IL298414B2 (en) 2017-02-28 2024-12-01 Immunogen Inc Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
KR20250008984A (ko) 2017-05-18 2025-01-16 리제너론 파마슈티칼스 인코포레이티드 사이클로덱스트린 단백질 약물 접합체
CA3247730A1 (en) 2017-11-07 2025-10-30 Regeneron Pharmaceuticals, Inc. Hydrophilic linkers for antibody drug conjugates
WO2019217591A1 (en) 2018-05-09 2019-11-14 Regeneron Pharmaceuticals, Inc. Anti-msr1 antibodies and methods of use thereof
WO2020014306A1 (en) * 2018-07-10 2020-01-16 Immunogen, Inc. Met antibodies and immunoconjugates and uses thereof
CN111228508B (zh) * 2018-11-29 2023-02-17 暨南大学 一种多靶点抗肿瘤的多肽药物偶联物及其制备方法与应用
AU2020240310A1 (en) 2019-03-21 2021-10-07 Immunogen, Inc. Methods of preparing cell-binding agent-drug conjugates
SG11202111109UA (en) * 2019-04-29 2021-11-29 Immunogen Inc Biparatopic fr-alpha antibodies and immunoconjugates
WO2024059263A1 (en) * 2022-09-15 2024-03-21 Immunogen, Inc. Methods for preparing maytansinoid derivatives with self-immolative peptide linkers
IL327670A (en) 2023-10-11 2026-06-01 Antikor Biopharma Ltd Antibodies, conjugates, and uses thereof
WO2025094146A1 (en) 2023-11-02 2025-05-08 Immunogen Switzerland Gmbh Vasconstrictors for reducing ocular toxicity of antibody-maytansinoid conjugates
CN119661863B (zh) * 2024-12-11 2025-12-19 嘉庚创新实验室 一种双重刺激响应性的聚硫辛酸类聚合物、纳米递送体系及其制备方法和应用

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2010129A (en) 1934-09-26 1935-08-06 Ingersoll Rand Co Valve assembly
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
EP0563475B1 (en) 1992-03-25 2000-05-31 Immunogen Inc Cell binding agent conjugates of derivatives of CC-1065
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
US20080152586A1 (en) 1992-09-25 2008-06-26 Avipep Pty Limited High avidity polyvalent and polyspecific reagents
US6355780B1 (en) 1995-02-22 2002-03-12 Yeda Research And Development Co. Ltd. Antibodies to the death domain motifs of regulatory proteins
ATE233552T1 (de) 1996-07-22 2003-03-15 Monsanto Co Thiol-sulfonen als metalloproteinaseinhibitoren
WO1999006587A2 (en) 1997-08-01 1999-02-11 Morphosys Ag Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
US7115396B2 (en) 1998-12-10 2006-10-03 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
HK1049997B (en) 1999-11-24 2007-02-23 Immunogen, Inc. Cytotoxic agents comprising taxanes and their therapeutic use
WO2002006214A1 (en) 2000-07-19 2002-01-24 Mitsubishi Pharma Corporation Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
US20030109682A1 (en) * 2001-09-07 2003-06-12 Daniel Santi Maytansines and maytansine conjugates
WO2003034903A2 (en) 2001-10-23 2003-05-01 Psma Development Company, L.L.C. Psma antibodies and protein multimers
US6716821B2 (en) 2001-12-21 2004-04-06 Immunogen Inc. Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
US6756397B2 (en) 2002-04-05 2004-06-29 Immunogen, Inc. Prodrugs of CC-1065 analogs
EP1534674A4 (en) 2002-08-02 2007-11-28 Immunogen Inc CYTOTOXIC AGENTS CONTAINING NEW, EFFECTIVE TAXANES AND THEIR THERAPEUTIC USE
EP1542723B1 (en) 2002-08-16 2011-02-23 ImmunoGen, Inc. Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs
DK1578446T3 (en) 2002-11-07 2015-06-29 Immunogen Inc ANTI-CD33 ANTIBODIES AND PROCEDURES FOR TREATING ACUTE MYELOID LEUKEMIA BY USING IT
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
EP1651162B1 (en) * 2003-05-20 2015-10-21 ImmunoGen, Inc. Improved cytotoxic agents comprising new maytansinoids
US7276497B2 (en) 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids
US7834155B2 (en) 2003-07-21 2010-11-16 Immunogen Inc. CA6 antigen-specific cytotoxic conjugate and methods of using the same
EA014640B1 (ru) 2003-07-21 2010-12-30 Иммьюноджен, Инк. Антитело или его эпитоп-связывающий фрагмент, которые связываются с гликотопом са6, и способы их применения
US8039588B2 (en) 2004-05-21 2011-10-18 The Uab Research Foundation Variable lymphocyte receptors
NZ551180A (en) 2004-06-01 2009-10-30 Genentech Inc Antibody drug conjugates and methods
US20080305044A1 (en) 2004-11-29 2008-12-11 Seattle Genetics, Inc. Engineered Antibodies and Immunoconjugates
KR101268939B1 (ko) 2005-07-08 2013-05-30 유니버시티 오브 취리히 융합 폴리펩티드의 공번역 전좌를 사용한 파아지디스플레이
EA020130B9 (ru) 2005-08-22 2014-10-30 Иммьюноджен, Инк. Специфичное к антигену са6 антитело, содержащий его цитотоксический конъюгат и способы применения конъюгата
EP1962961B1 (en) 2005-11-29 2013-01-09 The University Of Sydney Demibodies: dimerisation-activated therapeutic agents
EP1996612A4 (en) 2006-03-03 2010-10-20 Univ Kingston COMPOSITIONS FOR THE TREATMENT OF CANCER
PT2032606E (pt) 2006-05-30 2014-02-05 Genentech Inc Anticorpos e imunoconjugados e respetivas utilizações
CA2655379A1 (en) 2006-06-22 2007-12-27 Walter And Eliza Hall Institute Of Medical Research Structure of the insulin receptor ectodomain
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
NZ588884A (en) 2008-04-30 2013-05-31 Immunogen Inc Cross-linkers and their uses
UA108598C2 (xx) 2008-04-30 2015-05-25 Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери)
MX2011004550A (es) 2008-10-31 2011-07-20 Centocor Ortho Biotech Inc Composiciones de de supercóntigos a base de dominios de fibronectina tipo iii, métodos y usos.
GB0913775D0 (en) 2009-08-06 2009-09-16 Medical Res Council Multispecific peptides
CN102596992B (zh) 2009-02-12 2015-09-09 詹森生物科技公司 基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途
CA2784610C (en) 2009-12-23 2020-07-14 Avipep Pty Ltd Immuno-conjugates and methods for producing them
CN105777907B (zh) 2010-02-24 2020-03-17 伊缪诺金公司 叶酸受体1抗体与免疫缀合物以及其用途
LT2544719T (lt) 2010-03-12 2019-10-25 Debiopharm Int Sa Cd37 surišančios molekulės, ir jų imunokonjugatai
HUE029622T2 (en) 2010-04-30 2017-03-28 Janssen Biotech Inc Stabilized fibronectin domain compositions, methods and uses
CA2815277A1 (en) 2010-10-29 2012-05-03 Immunogen, Inc. Novel egfr-binding molecules and immunoconjugates thereof
JP5828902B2 (ja) 2010-10-29 2015-12-09 イミュノジェン, インコーポレイテッド 非拮抗性egfr結合分子およびその免疫複合体
EA033468B1 (ru) * 2011-03-29 2019-10-31 Immunogen Inc Способы получения конъюгата "антитело-майтансиноид"
ES2661466T3 (es) 2011-04-01 2018-04-02 Immunogen, Inc. Métodos para aumentar la eficacia de la terapia contra el cáncer con FOLR1
WO2012177837A2 (en) * 2011-06-21 2012-12-27 Immunogen, Inc. Novel maytansinoid derivatives with peptide linker and conjugates thereof
NL2009825C2 (en) * 2012-11-16 2014-05-21 Ipee Bvba Sanitary appliance and method of determining use thereof.
CN104688740A (zh) * 2012-12-21 2015-06-10 百奥泰生物科技(广州)有限公司 类美登素衍生物及其制备方法和用途
EA201591465A1 (ru) 2013-02-08 2015-12-30 АйАрЭм ЭлЭлСи Специфичные участки для модификации антител для получения иммуноконъюгатов
HK1219423A1 (zh) 2013-02-28 2017-04-07 Immunogen, Inc. 包含细胞结合剂及细胞毒素剂的轭合物
HK1219422A1 (zh) * 2013-02-28 2017-04-07 Immunogen, Inc. 包含细胞结合剂及细胞毒素剂的轭合物
EP2988786A4 (en) * 2013-04-22 2016-12-21 Avelas Biosciences Inc COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE
WO2014194030A2 (en) * 2013-05-31 2014-12-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
WO2015038426A1 (en) 2013-09-13 2015-03-19 Asana Biosciences, Llc Self-immolative linkers containing mandelic acid derivatives, drug-ligand conjugates for targeted therapies and uses thereof
CN105813653B (zh) 2013-12-19 2020-06-26 西雅图基因公司 与目标-药物偶联物并用的亚甲基氨基甲酸酯连接物
AU2015271100B2 (en) * 2014-06-06 2020-07-30 Redwood Bioscience, Inc. Anti-HER2 antibody-maytansine conjugates and methods of use thereof
SG11201701565PA (en) * 2014-09-03 2017-03-30 Immunogen Inc Conjugates comprising cell-binding agents and cytotoxic agents
US20170281796A1 (en) 2014-12-08 2017-10-05 Sorrento Therapeutics, Inc. c-Met Antibody Drug Conjugate
SMT202100092T1 (it) 2015-06-29 2021-03-15 Immunogen Inc Anticorpi anti-cd123 e loro coniugati e derivati
IL298414B2 (en) 2017-02-28 2024-12-01 Immunogen Inc Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
WO2020014306A1 (en) 2018-07-10 2020-01-16 Immunogen, Inc. Met antibodies and immunoconjugates and uses thereof

Similar Documents

Publication Publication Date Title
KR102923527B1 (ko) 생체활성 분자 접합체, 이의 제조 방법 및 용도
JP7645843B2 (ja) 自己犠牲型ペプチドリンカーを有するメイタンシノイド誘導体及びそのコンジュゲート
JP7402807B2 (ja) グリピカン3抗体およびそのコンジュゲート
CN107530422B (zh) Cd48抗体和其缀合物
CN110240654A (zh) 结合cd73的抗体-药物偶联物
JP2017529837A (ja) 細胞結合剤及び細胞毒性剤を含む複合体
CA3084495A1 (en) Humanized anti-liv1 antibodies for the treatment of breast cancer
WO2018036243A1 (zh) 靶向于组织因子的抗体-药物偶联物
TWI827575B (zh) 苯二氮平衍生物
JP2022547434A (ja) 標的化デンドリマー複合体
CN107614488A (zh) 新型亲水连接体和其在配体‑药物共轭偶联物上的应用
TWI897953B (zh) 包含抗ceacam5抗體接合物、三氟胸苷和替吡嘧啶的抗腫瘤組合
JP2023529640A (ja) 治療用コンジュゲート
CN115768484A (zh) 含有抗ceacam5抗体缀合物和伊立替康的抗肿瘤组合
JP2024545170A5 (cg-RX-API-DMAC7.html)
KR20220041851A (ko) 접합을 위한 폴리펩티드 복합체 및 이의 용도
CN110575548A (zh) 靶向于cd73的抗体-药物偶联物及其制法和用途
JP2024509891A (ja) 抗her2抗体-免疫アゴニストコンジュゲート及びその使用
CN115427082A (zh) 含有抗ceacam5抗体缀合物和folfox的抗肿瘤组合
JP2025533983A (ja) リンカー-ペイロード化合物、複合体、及びその用途
JP2025532285A (ja) 高安定性親水性リンカーユニットを有するアウリスタチン系薬物及びその複合体
CN120774988A (zh) 一种连接子、抗体药物偶联物及其制备方法
HK1248538B (en) Cd48 antibodies and conjugates thereof